Nucleus Hybrid Cochlear Implant
FDA premarket approval P130016/S041 · decided 2020-07-02
Approval details
- PMA number
- P130016
- Supplement
- S041
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- Nucleus Hybrid Cochlear Implant
- Generic name
- Cochlear implant with combined electrical stimulation and acoustic amplification
- Applicant
- Cochlear Americas
- Date received
- 2019-11-13
- Decision date
- 2020-07-02
- Days to decision
- 232 days
- Decision code
- APPR
- Product code
- PGQ
- Advisory committee
- Ear, Nose, Throat
- Expedited review
- No
- Location
- Lone Tree, CO
- Statement
- Approval for the Kanso 2 Sound Processor and associated accessories, Nucleus 7 for Nucleus 22, SmartNav System including SmartNav App and CP1150S Surgical Processor, and Custom Sound Pro.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.